Obesity
📧 Sign up to get email alerts when something new happens for Obesity.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-06-30Clinical Trial Update: Pretreatment of Patients Expecting Bariatric Surgery With the GLP-1 Analogon Liraglutid [Phase 3]
Phase 3 trial evaluating pre-treatment with a GLP-1 analog (liraglutide) in patients awaiting bariatric surgery was terminated.
-
FDA approval · 2022-06-24FDA Approved: PHENTERMINE AND TOPIRAMATE — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application from Prasco Laboratories for the combination drug phentermine/topiramate.
-
CLINICAL_TRIALS trial_result · 2022-06-23Clinical Trial Update: Pilot Study of the Effect of Liraglutide 3.0 mg on Weight Loss and Gastric Functions in Obesity [Phase 2]
Phase 2 pilot trial evaluating liraglutide 3.0 mg for weight loss and gastric function in obesity has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-06-22Clinical Trial Update: Thymol on Netrin-1 on Obese Patients [Phase 2]
Phase 2 trial update investigating thymol's effect on Netrin-1 in obese patients with inflammatory response.
-
CLINICAL_TRIALS research · 2022-06-21Clinical Trial Update: Skeletal Muscle Diacylglycerol and Sphingolipids - Impact of Localization and Species on Insulin Resistance in Humans [NA]
A completed clinical trial evaluating skeletal muscle lipids and their localization effects on insulin resistance in humans, involving Type …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-06-15FDA Approved: SAXENDA — Supplemental Application (Novo Nordisk)
FDA approved Novo Nordisk's supplemental application for SAXENDA (liraglutide), finalizing an updated labeling to support weight-management …
-
CLINICAL_TRIALS trial_result · 2022-06-15Clinical Trial Update: Bioavailability of SPMs in Obese Humans [NA]
Update on a completed clinical trial assessing the bioavailability of specialized pro-resolving mediators (SPMs) in obese adults.
-
CLINICAL_TRIALS trial_result · 2022-05-27Clinical Trial Update: PDE5 Inhibition for Obesity-Related Cardiometabolic Dysfunction [Phase 2]
Phase 2 trial investigating PDE5 inhibition for obesity-related cardiometabolic dysfunction has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-05-18Clinical Trial Update: Optimal Anesthesia for Morbidly Obese Patients [Phase 4]
Phase 4 clinical trial update on optimal anesthesia for morbidly obese patients completed.
-
CLINICAL_TRIALS trial_result · 2022-05-18Clinical Trial Update: Double-blinded, 6 Months Study With Bydureon® or Placebo in Adolescents With Obesity to Explore Changes in BMI [Phase 2]
Phase 2 double-blind trial in adolescents with obesity comparing Bydureon to placebo to assess changes in BMI is completed.
-
CLINICAL_TRIALS trial_result · 2022-05-11Clinical Trial Update: Protection Against Insulin Resistance in Obesity [NA]
A completed clinical trial from University of Michigan studying protection against insulin resistance in obesity; results posted in 2022.
-
CLINICAL_TRIALS withdrawal · 2022-05-06Clinical Trial Update: TC02 Obese Women Using It Morphine vs PCA IV Hydromorphone for Post-Cesarean Analgesia [Phase 4]
Phase 4 trial comparing morphine vs PCA IV hydromorphone for post-cesarean analgesia was withdrawn.
-
CLINICAL_TRIALS trial_result · 2022-05-05Clinical Trial Update: Evaluation of the Effect of Different Doses Dexmedetomidine Infusion on Lung Mechanics and Oxygenation in Obese Patients [Phase 2]
Phase 2 trial evaluating different dexmedetomidine infusion doses on lung mechanics and oxygenation in obese patients has completed.
-
CLINICAL_TRIALS trial_result · 2022-05-03Clinical Trial Update: The Effect of Bariatric Surgery on Metabolism, the Metabolome and Microbiome in Patients With Type 2 Diabetes [Phase 2]
Phase 2 trial investigating the metabolic, metabolomic, and microbiome effects of bariatric surgery in patients with type 2 diabetes and obe…
-
CLINICAL_TRIALS trial_result · 2022-05-03Clinical Trial Update: Intragastric Balloon in Obese Adolescents With Comorbidities [NA]
Clinical trial update on intragastric balloon use in obese adolescents with comorbidities; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-05-02Clinical Trial Update: Lorcaserin and Behavioral Modification for Overweight and Obesity Management in Chinese Obese Patients [Phase 3]
Phase 3 trial update on lorcaserin with behavioral modification for overweight/obesity in Chinese patients; study terminated.
-
CLINICAL_TRIALS trial_result · 2022-04-27Clinical Trial Update: Research Study to Investigate How Well Semaglutide Works Compared to Liraglutide in People Living With Overweight or Obesity [Phase 3]
A Phase 3 trial comparing semaglutide to liraglutide in adults with overweight or obesity has completed and results were posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-04-27Clinical Trial Update: Vestibular Stimulation to Trigger Adipose Loss Clinical Trial
A terminated clinical trial investigating vestibular stimulation for adipose loss in obesity and related conditions; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-04-08Clinical Trial Update: Pharmacokinetics of Simvastatin Post Laparoscopic Sleeve Gastrectomy (LSG) [Phase 4]
Clinical trial update examining pharmacokinetics of simvastatin after laparoscopic sleeve gastrectomy in obesity and hyperlipidemia patients…
-
CLINICAL_TRIALS trial_result · 2022-04-07Clinical Trial Update: Dysregulation of FSH in Obesity: Functional and Statistical Analysis [NA]
Completed clinical trial update examining dysregulation of follicle-stimulating hormone in obesity and its impact on fertility. The study in…
-
CLINICAL_TRIALS trial_result · 2022-04-05Clinical Trial Update: The Possible Effects of Roflumilast on Obesity Related Disorders [Phase 3]
Phase 3 clinical trial evaluating roflumilast for obesity-related disorders including obesity and prediabetes has been completed.
-
CLINICAL_TRIALS trial_result · 2022-04-05Clinical Trial Update: Protein Bioavailability of Wolffia Globosa (Mankai); Acute Test Meal Effects [NA]
A completed clinical trial evaluated the protein bioavailability of Wolffia globosa (Mankai) and acute meal effects in men with mild abdomin…
-
CLINICAL_TRIALS trial_result · 2022-04-04Clinical Trial Update: A Proof of Concept Trial in Overweight and Obese Patients, Investigating Effect of EMP16-02 on Body Weight (Primary) [Phase 1, Phase 2]
A proof-of-concept study investigating EMP16-02 for body weight reduction in overweight and obese patients; completed Phase 1/2.
-
CLINICAL_TRIALS trial_result · 2022-03-23Clinical Trial Update: Two-year Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity [Phase 3]
A Phase 3 trial evaluating the effectiveness of semaglutide in individuals who are overweight or obese has completed, with results posted in…
-
CLINICAL_TRIALS trial_result · 2022-03-23Clinical Trial Update: Empowered With Movement to Prevent Obesity and Weight Regain [NA]
Completed clinical trial investigating movement-based intervention to prevent obesity and weight regain, with results posted in 2022.